Sign inJoin waitlistJoin the waitlist

SM

Stacy Moulder

Internal Medicine

Credentials: · ·

History

Medical Oncology
1998–2000
Internal Medicine
1995–1998
University of Mississippi School of Medicine
1991–1995

Research

Palbociclib and Letrozole in Advanced Breast Cancer
New England Journal of Medicine · 2016 · 2,333 citations
High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types
Annals of Oncology · 2021 · 855 citations
Delineating copy number and clonal substructure in human tumors from single-cell transcriptomes
Nature Biotechnology · 2021 · 704 citations

Vicente Valero
46 papers
Razelle Kurzrock
36 papers
Jennifer Litton
34 papers
William Symmans
34 papers
Clinton Yam
30 papers · 7 as a fellow
Alastair Thompson
29 papers
Gaiane Rauch
29 papers
David Hong
28 papers
JW
Jennifer Wheler
28 papers
Gabriel Hortobagyi
26 papers
Aung Naing
25 papers · 1 as a fellow
Beatriz Adrada
24 papers

Clinical trials

Mirvetuximab Soravtansine as First Line in Treating Patients With Triple Negative Breast Cancer
Principal investigator · Completed · Phase 2
M.D. Anderson Cancer Center
2017–2019
Maximum Tolerated Dose (MTD) of Liposomal Doxorubicin in Combination With Seliciclib for Patients With Metastatic Triple Negative Breast Cancer (TNBC)
Principal investigator · Withdrawn · Phase 1
M.D. Anderson Cancer Center
2012
Dinaciclib and Epirubicin Hydrochloride in Treating Patients With Metastatic Triple-Negative Breast Cancer
Principal investigator · Completed · Phase 1
National Cancer Institute (NCI)
2012–2013
Personalized Treatment Selection for Metastatic Breast Cancer
Principal investigator · Terminated · Phase 2
M.D. Anderson Cancer Center
2009–2014